Search clinical trials for: Datopotamab deruxtecan Durvalumab
Total 844 results
-
Centre Leon BerardCompletedFRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel (FRAIL-IMMUNE)Squamous Cell Carcinoma of the Head and NeckFrance
-
NeoTX Therapeutics Ltd.AstraZenecaActive, not recruitingMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Ovarian Cancer | NSCLC | Prostate Cancer | Mesothelioma | Bladder Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Colorectal Cancer Metastatic | Head and Neck Squamous Cell Carcinoma | Urothelial Cancer | Cervical Squamous... and other conditionsIsrael
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Indiana UniversityRecruitingNSCLC, Stage IIIUnited States
-
Jeeyun LeeRecruitingStomach Cancer, AdenocarcinomaKorea, Republic of
-
AstraZenecaRecruiting
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, Australia, Korea, Republic of, Canada, Poland, Spain, Vietnam, Germany, Brazil, Italy, Japan, Taiwan, Thailand, United States, United Kingdom, Portugal, Turkey, France, Peru, Colombia, Russian Federation, Ukraine
-
Gruppo Oncologico del Nord-OvestRecruitingGastric Cancer | Microsatellite InstabilityItaly
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruitingProstate CancerCanada
-
Grupo Espanol de Tumores NeuroendocrinosMFARActive, not recruitingMetastatic Thyroid Cancer | Metastatic Thyroid Papillary Carcinoma | Metastatic Thyroid Follicular CarcinomaSpain
-
Advaxis, Inc.MedImmune LLCTerminatedCervical Cancer | Cancer | Head and Neck CancerUnited States
-
Centre hospitalier de l'Université de Montréal...AstraZenecaActive, not recruitingHead and Neck Squamous Cell Carcinoma | Metastatic Squamous Cell CarcinomaCanada
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationWithdrawnSolitary Bone PlasmacytomaUnited States
-
AIO-Studien-gGmbHAstraZenecaCompletedRecurrent Adult Soft Tissue Sarcoma | Metastatic Adult Soft Tissue SarcomaGermany
-
University of NebraskaAstraZenecaTerminatedSmall Cell Lung CarcinomaUnited States
-
Yale UniversityAstraZenecaWithdrawn
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingNon-small Cell Lung CancerFrance
-
M.D. Anderson Cancer CenterNektar TherapeuticsRecruitingLung CancerUnited States
-
University of Alabama at BirminghamUnited States Department of DefenseNot yet recruitingSarcoma | NF1 | MPNSTUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
University College, LondonAstraZeneca; Cancer Research UK; Kidney Cancer UKRecruiting
-
Memorial Sloan Kettering Cancer CenterCompletedEndometrial Cancer | Endometrial Carcinoma | Endometrial Carcinosarcoma | Endometrial Cancer Recurrent | Endometrial Carcinoma, RecurrentUnited States
-
M.D. Anderson Cancer CenterAstraZeneca; Mirati Therapeutics Inc.WithdrawnLung Cancer | Gastro-intestinal CancerUnited States
-
MedImmune LLCCompletedA Study of MEDI5395 in Combination With Durvalumab in Participants With Select Advanced Solid TumorsAdvanced Solid TumorsUnited States, United Kingdom
-
Gustave Roussy, Cancer Campus, Grand ParisWithdrawnMetastatic Colorectal Cancer | Triple Negative Breast Cancer | Esophageal Adenocarcinoma | Prostate Adenocarcinoma | Stomach Adenocarcinoma
-
Institut Català d'OncologiaAstraZeneca; BioClever 2005 S.L.; VCN Biosciences, S.L.Active, not recruitingRecurrence | Head and Neck Neoplasms | Metastasis | Carcinoma, Squamous Cell of Head and NeckSpain
-
Canadian Cancer Trials GroupAstraZenecaActive, not recruiting
-
European Organisation for Research and Treatment...WithdrawnSquamous Non-small Cell Lung Cancer | Non-Squamous Non-small Cell Lung Cancer
-
AstraZenecaDaiichi Sankyo Co., Ltd.RecruitingAdvanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)China
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHER2-positive Advanced Gastric Cancer | HER2-positive Gastroesophageal Junction AdenocarcinomaAustria, Belgium, Germany, Italy
-
AstraZenecaDaiichi SankyoActive, not recruitingHER2-mutant Non-Small Cell Lung CancerChina
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingPart 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer | Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal CancerBelgium, United States, Poland, India, Taiwan, Thailand, Korea, Republic of, Czechia, Russian Federation, United Kingdom, Spain, Australia, Canada, Italy, Netherlands
-
Peking Union Medical College HospitalRecruitingGastrointestinal Neuroendocrine CarcinomaChina
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
University Health Network, TorontoRecruiting
-
M.D. Anderson Cancer CenterMedImmune LLCActive, not recruitingAdvanced and/or Metastatic SarcomaUnited States
-
Alliance Foundation Trials, LLC.AstraZenecaActive, not recruitingStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung CancerUnited States
-
AstraZenecaApproved for marketing
-
Eli Lilly and CompanyAstraZenecaCompletedMetastatic Pancreatic CancerSpain, United States, Korea, Republic of, France, Italy
-
UNICANCERAstraZeneca; National Cancer Institute, France; Pierre Fabre LaboratoriesActive, not recruitingBreast Cancer | Head and Neck Cancer | Prostate Cancer | Cervix Cancer | Advanced Solid TumoursFrance
-
National Cancer Institute, NaplesRecruiting
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Institut BergoniéEpizyme, Inc.; AstraZenecaRecruitingAdult Solid Tumor | Advanced Solid Tumor | Advanced Pancreatic Adenocarcinoma | Advanced Colorectal Carcinoma | Advanced Soft-tissue SarcomaFrance
-
Abramson Cancer Center at Penn MedicineCompletedMelanoma | Breast Cancer | Pancreatic Cancer | Metastatic | Non Small Cell Lung Cancer (NSCLC)United States
-
Spanish Oncology Genito-Urinary GroupAstraZeneca; MFARActive, not recruiting
-
Pharmacyclics LLC.AstraZeneca; Janssen Research & Development, LLCCompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States
-
University of SouthamptonAstraZeneca; Natera, Inc.RecruitingGastrooesophageal CancerUnited Kingdom